Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.01 – $0.06
17% from low
Exchange
OTC Link
CS
Borrow rate
0.25%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2021 | 2023 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $28.4K | $43.1K | $2.3K | $0 | $0 | $1.2K | $0 | $0 |
| Cost of revenue | $109.1K | $131.1K | $81.4K | $264 | $140 | $561 | $0 | $0 |
| Gross profit | −$80.7K | −$87.9K | −$79.1K | −$264 | −$140 | $679 | $0 | $0 |
| Gross margin | -284.5% | -203.8% | -3515.9% | — | — | 54.8% | — | — |
| R&D | $28.3K | $3.7K | $0 | $0 | $0 | $365.1K | $711.5K | $181.0K |
| Operating income | −$175.1K | −$292.4K | −$334.0K | −$134.4K | −$121.3K | −$1.3M | −$1.4M | −$513.3K |
| EBITDA | −$174.7K | −$292.0K | −$333.7K | −$134.1K | −$121.2K | −$1.3M | −$1.4M | −$513.3K |
| Net income | −$175.1K | −$295.6K | −$381.1K | −$42.8M | −$132.7K | −$1.3M | −$1.4M | −$567.0K |
| Net margin | -617.2% | -685.2% | -16937.8% | — | — | -108092.5% | — | — |
| EPS (diluted) | -29.39 | -49.65 | -68.95 | -7736.50 | -0.07 | -0.39 | -0.04 | -0.01 |
Annual figures · source: Financial Modeling Prep
AGENTIX CORP
No one on the platform currently holds AGTX.
No tracked institution reports a position in AGTX as of their last filing.
| Execution date | Ratio |
|---|---|
| 2020-02-25 | 100-for-1 |
No one on the platform has traded AGTX yet.
| $7M |
| — |
| HESGHealth Sciences Group, Inc. | $0.00 | +0.00% | $2M | — |
| IBOGFUniversal Ibogaine Inc. | $0.03 | +3.81% | $8M | — |
Source: Financial Modeling Prep · peers by sector/industry
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.